BeOne Medicines AG
BeOne Medicines AG (NASDAQ: ONC) is trading at $360.85, about ₹34,613 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, up 0.24% today. Indian residents can buy BeOne Medicines from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$359.83
Today's high
$365.00
52 week low
$253.95
52 week high
$385.22
ONC opened at $362.51, closed previously at $359.97, and has traded between $253.95 and $385.22 over the past 52 weeks.
About
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK targeting chimeric degradation activation compound active against wild type and mutant BTK; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187 and BG-C0902, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.
Key statistics
Avg. volume
356.09K
Market cap
$38.56B
P/E Ratio
25.71
Price-to-sales ratio
6.53
Enterprise value
$36.29B
Free cash flow yield
3.27%
Debt-to-equity ratio
0.22
Return on equity
14.27%
ROIC
9.63%
Beta
0.52
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$5.34B
Earnings per share
$33.80
Free cash flow
$941.74M
Net profit margin
10.68%
Gross margin
87.82%
EBITDA
$616.77M
Revenue growth
40.23%
Similar securities
This is not an investment recommendation
How to buy BeOne Medicines from India
Indian residents can buy BeOne Medicines shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for BeOne Medicines and place an order
Find BeOne Medicines by name or by its ticker, ONC, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. BeOne Medicines trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your BeOne Medicines position in USD and INR. BeOne Medicines pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in BeOne Medicines from India
Trading and taxes when buying BeOne Medicines from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneBeOne Medicines does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy BeOne Medicines stock?
Yes. BeOne Medicines (ONC) has been listed on NASDAQ since 2016, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one BeOne Medicines share cost in rupees?
One BeOne Medicines share is $360.85 — about ₹34,613 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the BeOne Medicines price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying BeOne Medicines from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy BeOne Medicines with less than the price of one share?
Yes. A whole BeOne Medicines share is $360.85, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.
How are gains on BeOne Medicines shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the BeOne Medicines price. Paasa issues a capital-gains statement for your return.
Does BeOne Medicines pay a dividend?
No. BeOne Medicines does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade BeOne Medicines from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is BeOne Medicines a United States company, and does that change how it is taxed?
BeOne Medicines trades on NASDAQ in US dollars, but the company is domiciled in Switzerland. BeOne Medicines trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare BeOne Medicines shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your BeOne Medicines holding, its cost and its closing value.
How do I sell BeOne Medicines and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.